# Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder

> **NCT01148472** · PHASE4 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 294 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT01148472
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-09
- **Final completion:** 2006-11
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148472, "Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01148472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*